Gedawy A, Martinez J, Al-Salami H, Dass CR (February 2018). “Oral insulin delivery: existing barriers and current counter-strategies”. 《The Journal of Pharmacy and Pharmacology》 70 (2): 197–213. doi:10.1111/jphp.12852. PMID29193053. S2CID12848146.지원되지 않는 변수 무시됨: |name-list-style= (도움말)
Khan F, Mukhtar S, Anjum F, Tripathi B, Sriprasad S, Dickinson IK, Madaan S (April 2013). “Fournier's gangrene associated with intradermal injection of cocaine”. 《The Journal of Sexual Medicine》 10 (4): 1184–1186. doi:10.1111/jsm.12055. PMID23347293.지원되지 않는 변수 무시됨: |name-list-style= (도움말)
Meng H, Cao J, Kang J, Ying X, Ji J, Reynolds W, Rampe D (January 2012). “Mephedrone, a new designer drug of abuse, produces acute hemodynamic effects in the rat”. 《Toxicology Letters》 208 (1): 62–68. doi:10.1016/j.toxlet.2011.10.010. PMID22037396.지원되지 않는 변수 무시됨: |name-list-style= (도움말)
Mathaes R, Koulov A, Joerg S, Mahler HC (August 2016). “Subcutaneous Injection Volume of Biopharmaceuticals-Pushing the Boundaries”. 《Journal of Pharmaceutical Sciences》 105 (8): 2255–2259. doi:10.1016/j.xphs.2016.05.029. PMID27378678.지원되지 않는 변수 무시됨: |name-list-style= (도움말)
Thomaidou E, Ramot Y (March 2019). “Injection site reactions with the use of biological agents”. 《Dermatologic Therapy》 32 (2): e12817. doi:10.1111/dth.12817. PMID30637967. S2CID58544258.
Gedawy A, Martinez J, Al-Salami H, Dass CR (February 2018). “Oral insulin delivery: existing barriers and current counter-strategies”. 《The Journal of Pharmacy and Pharmacology》 70 (2): 197–213. doi:10.1111/jphp.12852. PMID29193053. S2CID12848146.지원되지 않는 변수 무시됨: |name-list-style= (도움말)
Khan F, Mukhtar S, Anjum F, Tripathi B, Sriprasad S, Dickinson IK, Madaan S (April 2013). “Fournier's gangrene associated with intradermal injection of cocaine”. 《The Journal of Sexual Medicine》 10 (4): 1184–1186. doi:10.1111/jsm.12055. PMID23347293.지원되지 않는 변수 무시됨: |name-list-style= (도움말)
Meng H, Cao J, Kang J, Ying X, Ji J, Reynolds W, Rampe D (January 2012). “Mephedrone, a new designer drug of abuse, produces acute hemodynamic effects in the rat”. 《Toxicology Letters》 208 (1): 62–68. doi:10.1016/j.toxlet.2011.10.010. PMID22037396.지원되지 않는 변수 무시됨: |name-list-style= (도움말)
Mathaes R, Koulov A, Joerg S, Mahler HC (August 2016). “Subcutaneous Injection Volume of Biopharmaceuticals-Pushing the Boundaries”. 《Journal of Pharmaceutical Sciences》 105 (8): 2255–2259. doi:10.1016/j.xphs.2016.05.029. PMID27378678.지원되지 않는 변수 무시됨: |name-list-style= (도움말)
Thomaidou E, Ramot Y (March 2019). “Injection site reactions with the use of biological agents”. 《Dermatologic Therapy》 32 (2): e12817. doi:10.1111/dth.12817. PMID30637967. S2CID58544258.
Gedawy A, Martinez J, Al-Salami H, Dass CR (February 2018). “Oral insulin delivery: existing barriers and current counter-strategies”. 《The Journal of Pharmacy and Pharmacology》 70 (2): 197–213. doi:10.1111/jphp.12852. PMID29193053. S2CID12848146.지원되지 않는 변수 무시됨: |name-list-style= (도움말)
Thomaidou E, Ramot Y (March 2019). “Injection site reactions with the use of biological agents”. 《Dermatologic Therapy》 32 (2): e12817. doi:10.1111/dth.12817. PMID30637967. S2CID58544258.